Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L BORN

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|January 15, 1988
Regioselective formation of a misonidazole-glutathione conjugate as a function of pH during chemical reductionE Chacon, C J Morrow, A A Leon, et al.
Toxicology and Applied Pharmacology|July 1, 1995
Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissuesJ A Krieger, D R Davila, J Lytton, et al.
Toxicology and Applied Pharmacology|May 1, 1997
Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cellsD L Romero, B J Mounho, F T Lauer, et al.
JAMA|May 24, 1976
Heavy-particle therapy in acromegaly and Cushing diseaseJ H Lawrence, C A Tobias, J A Linfoot, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1994
Polycyclic aromatic hydrocarbons decrease intracellular glutathione levels in the A20.1 murine B cell lymphomaJ W Yuan, J A Krieger, K R Maples, et al.
Transactions of the American Clinical and Climatological Association|March 17, 2011
Alpha and Proton Heavy Particles and the Bragg Peak in TherapyJ H Lawrence, C A Tobias, J L Born, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1994
Inhibition of humoral immunity and mitogen responsiveness of lymphoid cells following oral administration of the heterocyclic food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to B6C3F1 miceD A Davis, M M Archuleta, J L Born, et al.
Human Pathology|January 1, 1984
Delayed sequelae of pituitary irradiationK H Woodruff, J T Lyman, J H Lawrence, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1970
Human growth hormone levels in cerebrospinal fluidJ A Linfoot, J F Garcia, W Wei, et al.
The New England Journal of Medicine|November 1, 1971
Heavy-particle treatment of Cushing's diseaseJ H Lawrence, M D Okerlund, J A Linfoot, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|January 15, 1988
Regioselective formation of a misonidazole-glutathione conjugate as a function of pH during chemical reductionE Chacon, C J Morrow, A A Leon, et al.
Toxicology and Applied Pharmacology|July 1, 1995
Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissuesJ A Krieger, D R Davila, J Lytton, et al.
Toxicology and Applied Pharmacology|May 1, 1997
Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cellsD L Romero, B J Mounho, F T Lauer, et al.
JAMA|May 24, 1976
Heavy-particle therapy in acromegaly and Cushing diseaseJ H Lawrence, C A Tobias, J A Linfoot, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1994
Polycyclic aromatic hydrocarbons decrease intracellular glutathione levels in the A20.1 murine B cell lymphomaJ W Yuan, J A Krieger, K R Maples, et al.
Transactions of the American Clinical and Climatological Association|March 17, 2011
Alpha and Proton Heavy Particles and the Bragg Peak in TherapyJ H Lawrence, C A Tobias, J L Born, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1994
Inhibition of humoral immunity and mitogen responsiveness of lymphoid cells following oral administration of the heterocyclic food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to B6C3F1 miceD A Davis, M M Archuleta, J L Born, et al.
Human Pathology|January 1, 1984
Delayed sequelae of pituitary irradiationK H Woodruff, J T Lyman, J H Lawrence, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1970
Human growth hormone levels in cerebrospinal fluidJ A Linfoot, J F Garcia, W Wei, et al.
The New England Journal of Medicine|November 1, 1971
Heavy-particle treatment of Cushing's diseaseJ H Lawrence, M D Okerlund, J A Linfoot, et al.
Pageof 4